Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$727M |
| 2 |
Home Depot
HD
|
+$472M |
| 3 |
Pfizer
PFE
|
+$362M |
| 4 |
Texas Instruments
TXN
|
+$314M |
| 5 |
LyondellBasell Industries
LYB
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$567M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$245M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$242M |
| 4 |
AT&T
T
|
+$170M |
| 5 |
Accenture
ACN
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
CorMedix
CRMD
$591M
| $541K | ﹤0.01% |
98,690
+4,401
| +5% | +$20.2K |
|
3077
Curis
CRIS
$9.78M
| $538K | ﹤0.01% |
564
+19
| +3% | +$24.3K |
|
3078
SkyWater Technology
SKYT
$1.6B
| $538K | ﹤0.01% |
49,660
-2,893
| -6% | -$31.8K |
|
3079
Avita Medical
RCEL
$135M
| $537K | ﹤0.01% |
63,279
+1,201
| +2% | +$11.1K |
|
3080
Comscore
SCOR
$106M
| $535K | ﹤0.01% |
9,184
| – | – |
|
3081
American Superconductor
AMSC
$1.42B
| $534K | ﹤0.01% |
70,125
+774
| +1% | +$6.63K |
|
3082
Heritage Insurance Holdings
HRTG
$889M
| $532K | ﹤0.01% |
74,430
+9,541
| +15% | +$59.1K |
|
3083
BioAtla
BCAB
$5.46M
| $531K | ﹤0.01% |
2,121
-250
| -11% | -$105K |
|
|
WEBR
3084
DELISTED
Weber Inc.
WEBR
| $531K | ﹤0.01% |
53,983
+7,489
| +16% | +$80.7K |
|
3085
BlackSky Technology
BKSY
$943M
| $529K | ﹤0.01% |
34,981
+862
| +3% | +$18K |
|
3086
Donegal Group Class A
DGICA
$731M
| $526K | ﹤0.01% |
39,204
+2,213
| +6% | +$30.9K |
|
3087
RxSight
RXST
$249M
| $526K | ﹤0.01% |
42,470
+19,835
| +88% | +$238K |
|
3088
Caesarstone
CSTE
$72.3M
| $524K | ﹤0.01% |
49,770
+518
| +1% | +$6.14K |
|
3089
Prelude Therapeutics
PRLD
$366M
| $524K | ﹤0.01% |
75,930
-9,207
| -11% | -$84.2K |
|
|
FUV
3090
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $523K | ﹤0.01% |
3,952
| – | – |
|
3091
ClearPoint Neuro
CLPT
$448M
| $520K | ﹤0.01% |
49,887
+2,532
| +5% | +$23K |
|
3092
ARS Pharmaceuticals
SPRY
$509M
| $518K | ﹤0.01% |
147,375
-1,568
| -1% | -$6.83K |
|
3093
Annexon
ANNX
$835M
| $516K | ﹤0.01% |
188,717
-6,235
| -3% | -$38.4K |
|
|
ATCX
3094
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $516K | ﹤0.01% |
42,789
+1,488
| +4% | +$15.5K |
|
3095
Consolidated Water Co
CWCO
$467M
| $515K | ﹤0.01% |
46,550
+10,588
| +29% | +$107K |
|
|
TRML
3096
DELISTED
Tourmaline Bio
TRML
| $513K | ﹤0.01% |
5,206
+235
| +5% | +$22K |
|
3097
Lineage Cell Therapeutics
LCTX
$269M
| $512K | ﹤0.01% |
332,406
+17,052
| +5% | +$26.5K |
|
3098
Vitamin Cottage Natural Grocers
NGVC
$739M
| $512K | ﹤0.01% |
26,121
+6,827
| +35% | +$113K |
|
3099
Legacy Housing
LEGH
$625M
| $509K | ﹤0.01% |
23,676
| – | – |
|
|
ONIT
3100
Onity Group
ONIT
$309M
| $509K | ﹤0.01% |
21,417
+795
| +4% | +$26K |
|
Similar funds
Charles Schwab's Q1 2022 Portfolio in Review
As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.
- Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
- Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
- Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
- Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
- Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
- Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.
Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.